Skip to main content
International Archives of Otorhinolaryngology logoLink to International Archives of Otorhinolaryngology
. 2026 Mar 3;30(1):1–7. doi: 10.1055/s-0045-1812320

Larynx Injuries After Orotracheal Intubation: What are Risk Factors Observed in Patients with Covid?

Leticia Felix 1, Gabriel de Souza Mares 1, Lara Freire Bezerril Soares 1, Romualdo Suzano Louzeiro Tiago 1,, Sergio Roberto Nacif 2
PMCID: PMC12956407  PMID: 41783036

Abstract

Objective

To evaluate the risk factors for the development of laryngotracheal injuries in patients with coronavirus disease 2019 (COVID-19) undergoing orotracheal intubation (OTI).

Methods

A cohort study was performed with intubated patients diagnosed with COVID-19, hospitalized from March 1st to October 31st, 2020. They were called for outpatient follow-up after being discharged from the hospital.

Results

There were 421 patients with COVID-19 (31%) who required OTI, of which the outcome was: hospital discharge for 172 (40.9%) and death for 249 (59.1%). Outpatient videoendoscopy was performed in 95 patients (55.2%).

Conclusion

We observed a greater risk for the development of laryngotracheal injury in patients who presented an increase in leukocyte count at hospital admission with lymphopenia, hypoalbuminemia, increased arterial lactate, troponin, and total bilirubin, as well as endotracheal tube with larger caliber and pronation. Furthermore, patients who at the time of OTI showed greater inflammatory reactivity or developed coagulation disorders were also at greater risk.

Keywords: COVID-19, SARS-CoV-2, laryngostenosis, larynx

Introduction

Upper airway complications after orotracheal intubation (OTI) were considered a result of tissue ischemia due to endotracheal cuff pressures that compromise mucosal blood flow. 1 Although generally rare, they still constitute an important factor in morbidity after OTI, including damage to vocal cords, laryngotracheal stenosis or granuloma formation, and impaired swallowing. 2 3 4

Predisposing factors already described in the literature for the development of such complications include some intrinsic to the patient, such as comorbidities and immunity, as well as extrinsic factors, such as OTI tube size, excessive cuff pressure, and prolonged intubation before tracheostomy. 5 6 7 8

In the context of the coronavirus disease 2019 (COVID-19) pandemic, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus's rapid spread has led to an unprecedented increase in the number of patients requiring prolonged intensive care unit stays. 9 About 5% of individuals with this disease progress to severe conditions requiring mechanical ventilation. 10 In adults requiring mechanical ventilation, due to moderate-to-severe hypoxemic respiratory syndrome, the pronation position for 12 to 16 hours has been used, and it is often used in severe cases of COVID-19. 11 The goal of the present study was to evaluate the risk factors for the development of laryngotracheal injuries in COVID-19 patients, with severe clinical status, undergoing OTI.

Methods

The present study was evaluated and approved by the Research Ethics Committee of the institution (protocol No. 37097920.9.0000.5463). According to the Declaration of Helsinki, written informed consent was obtained from each patient or a legal representative in case of mental incapacity.

A prospective cohort study was conducted with consecutive COVID-19 patients diagnosed by a reverse transcription polymerase chain reaction (RT-PCR) molecular test, hospitalized in a tertiary hospital from March 1 to October 31, 2020, who required OTI. The procedure was performed by the rapid response team of the institution, composed of the anesthesiology team. All patients submitted to OTI were evaluated regarding the outcome: discharge or death. Patients who had been discharged from the hospital were called for outpatient follow-up and endoscopic examination (video nasopharyngeal laryngoscopy and videolaryngoscopy). The videoendoscopy evaluation was performed between the 25 th and 185 th days, with an average of 100 and a median of 93 days.

Patients were excluded from this study if they had changes or laryngeal comorbidities prior to COVID-19 infection, were unable to perform the exam or come to the hospital, and/or did not have laboratory diagnosis by RT-PCR molecular test for COVID-19. For their evaluation, the following data were collected: presence of laryngotracheal injury; age (adults: < 60-years-old; and elderly: > 60-years-old); sex; OTI duration (days); comorbidities (diabetes mellitus, systemic arterial hypertension, and obesity); endotracheal tube (ETT) size; tracheostomy; indication of pronation during the OTI period; troponin, ferritin, potassium, D-dimer, leukocyte and lymphocyte count, platelets, hemoglobin, total bilirubin and lactic dehydrogenase (LDH), albumin, and arterial lactate from the date of hospital admission; use of corticosteroid therapy and use of anticoagulant during hospitalization; C-reactive protein, D-dimer, activated partial thromboplastin time (APTT), prothrombin time (TP), and international normalized ratio (INR) from the date of OTI.

Patients underwent endoscopic examination of the laryngotracheal segment with the use of a flexible rhinolaryngoscope, model 11101 RP2, (Karl Storz SE & Co. KG) and a laryngeal endoscope, model 8706 CA (Karl Storz SE & Co. KG). The monitor used was the Tele Pack X LED system (Karl Storz SE & Co. KG) which includes an endoscope, TP 45-1 06/2014/EW-PT. The exams were recorded in an Ultra USB 3.0 64 GB pen drive (SanDisk Corp., model SDCZ48-064G).

The steps of a laryngotracheal segment endoscopy were static evaluation of the larynx (supraglottis, glottis, and subglottis) and trachea during inspiration; maximum phonation time; and emission of vowels /e/ and /i/. The exams were analyzed by three laryngologists, without prior knowledge of patient data, independently. The diagnosis of the injury was obtained from the agreement of two or more examiners.

The data was tabulated in the Excel (Microsoft Corp.) program and submitted to statistical analysis with the Minitab Statistical Software (Minitab, LLC), version 19.1.1. Nominal qualitative variables were summarized through descriptive statistics. For analysis and outcome of categorical qualitative variables, the Pearson chi-square test was used. For analysis and outcome of the correlation of continuous variables, the binary logistic regression test was applied. The results were considered statistically significant when the p- value was lower than 0.05.

Results

During the period of the present study, 1,357 patients were hospitalized with a diagnosis of COVID-19 confirmed by molecular RT-PCR test on nasal swab. The OTI for mechanical ventilation was required in 421 patients (31%). In patients submitted to this procedure, the outcomes found were hospital discharge in 172 (40.9%) and death in 249 (59.1%). Outpatient videoendoscopy evaluation was performed in 95 patients (55.2%). The group of patients who were discharged from hospital and were not examined represented 44.8% of the sample (n = 77). The reasons for absences were: 33 patients were unreachable (19.2%); 24 were not physically able to attend (14%); 15 refused the evaluation (8.7%); and 5 died after hospital discharge (2.9%). The average age of patients with COVID-19 submitted to OTI and evaluated by videoendoscopy was 59 years.

The videoendoscopy evaluation was performed between the 25 th and 185 th day, with an average of 100 and a median of 93 days. For this evaluation, inflammatory injuries (hyperemia and granuloma) and scarring (stenosis and immobility) were considered. Laryngotracheal injuries were observed in 38 patients (40%), with the most diverse forms of presentation, such as hyperemia, granulomas, and stenosis. Laryngotracheal lesions were observed in 38 patients (40%), including hyperemia (6.3%), granulomas (15.8%), unilateral immobility (1%), and stenosis (16.9%), as shown in Figs. 1 , 2 .

Fig. 1.

Fig. 1

Laryngeal image on inspiration with granuloma in the right vocal process and hyperemia in the left vocal process.

Fig. 2.

Fig. 2

Laryngeal image on inspiration with stenosis in the posterior region of the glottis (type II) and granulation in bilateral vocal process.

Among the 421 patients who required ventilatory support in the intensive care unit, tracheostomy was performed in 27 between day 7 and 37 after OTI. In the group that received hospital discharge (n = 172), only 2 underwent tracheostomy (1.2%). These patients were evaluated, and no OTI-related injury was observed. Statistical significance was observed for the development of laryngotracheal injury to the following factors: increased leukocyte count; lymphopenia; total bilirubin, albumin, arterial lactate, and troponin from the date of hospital admission; endotracheal tube size; indication of pronation during intubation; and increased leukocyte count, D-dimer, prothrombin time (PT), and INR on the date of OTI ( Tables 1 2 3 4 ).

Table 1. Logistic regression data on the day of admission.

Variables OR 95% CI p -value
Age 0.986 (0.958–1.016) 0.354
Platelets 10.019 (0.9972; 1.0067) 0.425
Total bilirubin 1.114870743 (357.5440–3.47632E + 07) 0.000
D-dimer 0.9459 (0.8462–1.0574) 0.251
Ferritin 10.002 (0.9997–1.0006) 0.433
Potassium 0.6237 (0.2890–1.3461) 0.208
Albumin 0.2217 (0.0782–0.6283) 0.001
LDH 10.042 (0.9996–1.0088) 0.065
Arterial lactate 17.021 (1.0156–2.8526) 0.038
AST 10.039 (0.9946–1.0132) 0.412
ALT 10.020 (0.9900–1.0142) 0.742
Troponin I 0.0000 (0.0000–0.0059) 0.004
Lymphocytes (%) 0.8430 (0.7627–0.9317) 0.000
PCR 10.396 (0.9958–1.0853) 0.072
Difference final–initial D-dimer 10.611 (0.9987–1.1274) 0.035
Hemoglobin 1.0476 (0.6861–1.5497) 0.829
Leukocytes 10.238 (0.9367–1.1191) 0.04

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval; CRP, C-reactive protein; LDH, lactic dehydrogenase; OR, odds ratio; PCR, polymerase chain reaction.

Table 2. Logistic regression data on the day of intubation.

Variables OR 95% CI p -value
D-dimer 1.030 (0.982–1.080) 0.219
INR 37.433789 (83.9308–1.669E + 07) 0.000
Leukocyte count 1.057 (1.002–1.154) 0.011
PCR 1.002 (0.979–1.025) 0.883
PT 2.4356 (1.360–4.352) 0.001
APTT 1.009 (0.962–1.059) 0.715
Fibrinogen 10.007 (0.9988–1.0026) 0.452
OTI days 0.958 (0.096–1.015) 0.131
ETT size 0.008
7.5 vs 7.0 0.521 (0.078–3.489)
7.0 vs 8.0 2.768 (0.497–15.420)
8.0 vs 7.5 5.314 (1.786–15.816)

Abbreviations: APTT, activated partial thromboplastin time; CI, confidence interval; CRP, C-reactive protein; INR, international normalized index; ETT, endotracheal tube; OR, odds ratio; OTI, orotracheal intubation; PCR, polymerase chain reaction; PT, prothrombin time.

Table 3. Qualitative variables data on the day of hospital admission.

Variables Injury p -value
Yes No
Sex 0.502
 Male 22 (23%) 29 (31%)
 Female 16 (17%) 28 (29%)
Age 0.180
 Adults 20 (21%) 28 (29%)
 Elderly 18 (19%) 29 (31%)
Comorbidities
SAH 0.355
 Yes 23 (24%) 29 (31%)
 No 15 (16%) 28 (29%)
DM 0.272
 Yes 12 (13%) 16 (17%)
 No 26 (27%) 41 (43%)
Obesity 0.713
 Yes 19 (20%) 22 (23%)
 No 19 (20%) 35 (37%)
OTI days 0.366
 Short 8 (8%) 9 (9%)
 Long 30 (32%) 48 (51%)
Heparinization 0.844
 Intermediary 21 (22%) 30 (32%)
 Prophylactic 7 (7%) 10 (11%)
 Full 9 (10%) 17 (18%)
Corticosteroid therapy 0.142
 Yes 27 (28%) 32 (34%)
 No 11 (12%) 25 (26%)

Abbreviations: DM, diabetes mellitus; OTI, orotracheal intubation; SAH, systemic arterial hypertension.

Table 4. Qualitative variables on the day of intubation.

Injury p -value
Variables Yes No
Tracheostomy* 0.515
 Yes 0 (0%) 2 (2%)
 No 38 (40%) 55 (58%)
Leukogram* 0.027
 > 11 16 (17%) 22 (23%)
 ≤11 12 (13%) 45 (47%)
CRP* 0.315
 < 10 27 (28%) 30 (32%)
 ≥10 16 (17%) 22 (23%)
D-dimer* 0.014
 Normal 2 (2%) 14 (15%)
 Changed 36 (38%) 43 (45%)
APTT* 0.715
 Normal 37 (39%) 56 (59%)
 Changed 1 (1%) 1 (1%)
PT* 0.001
 Normal 34 (36%) 56 (59%)
 Changed 4 (4%) 1 (1%)
INR* 0.021
 Normal 29 (31%) 53 (56%)
 Changed 9 (9%) 4 (4%)
Pronation indication* 0.001
 Yes 27 (28%) 20 (21%)
 No 11 (12%) 37 (39%)

Abbreviations: APTT, activated partial thromboplastin time; CRP, C-reactive protein; INR, international normalized ratio; PT, prothrombin time.

Note: *Date of intubation.

Discussion

Most laryngeal injuries after OTI have spontaneous resolution due to the regenerative capacity of the epithelium. However, under certain circumstances that lead to the aggravation of tissue perfusion and poor healing, the evolution of this process can get worse and lead to laryngeal injuries of variable gravity. 11 The main risk factors for postintubation laryngotracheal injuries described in the literature include: total duration, tracheal tube size, depth of sedation, and previous conditions (cardiovascular diseases, diabetes, smoking, and obesity). 12 13 14

In the present study, we evaluated patients who were admitted to an intensive care unit, with the need for OTI, all with a high degree of complexity and severe clinical status. Within this group, we searched for risk factors for postprocedure laryngotracheal injury, such as endotracheal tube size, pronation, and laboratory changes related to inflammation and coagulation.

The COVID-19 infection leads to deregulated immune response, generating leukocytosis at the expense of neutrophils and lymphopenia, explained by an immune suppression stage after the proinflammatory phase. 15 16 Studies have shown that the degree of lymphopenia and proinflammatory cytokine storm are independent risk factors for severe disease in this cohort. 17 18 In this study, we found a statistically significant correlation between increased leukocyte count and lymphopenia at the moment of hospital admission in patients who developed laryngotracheal injury after OTI, as well as increased leukocytes at the time of intubation ( Tables 1 , 2 , and 4 ). Ghosh et al. in a study with severe combined immunodeficient mice were able to demonstrate that circulating host systemic immune mediators, such as T and B leukocytes, play roles at the beginning of granulation tissue formation in response to tissue trauma in the airway. 19

Studies carried out on patients with COVID-19 suggest that the ventral position could be a risk factor for laryngotracheal complications. 4 20 21 22 In the present study, we observed that the pronation position during OTI was associated with the presence of laryngotracheal injuries ( Table 4 ). This position can cause ETT displacement, press the cuff on the tracheal walls, and generate ischemic injury to the laryngotracheal segment. 23 24 25 In the present study, according to institutional protocol, the cuff was inflated with a minimum volume to seal the trachea and with a maximum pressure of 30 cmH2O after OTI, with continuous monitoring.

The COVID-19 infection provides a prothrombotic and antifibrinolytic state, associated with increased concentrations of D-dimer and other fibrin degradation products, which were significantly associated with worse prognosis and higher mortality. 26 27 Coagulation alterations (increase in D-dimer throughout hospitalization, PT, and INR) were important prognostic factors for the development of laryngotracheal injury ( Tables 1 2 3 4 ). The prothrombotic state in COVID-19 determines microvascular injury, with potential development of ischemia and necrosis of the laryngotracheal mucosa. 20 28

Factors that can be modified (e.g., ETT size) are significantly associated with an increased risk of developing laryngotracheal injury after OTI. 29 30 In this study, based on the multivariable logistic regression model, we observed that the ETT number 7.0 was associated with a lower injury probability when compared to higher caliber tubes ( Table 2 ). In the pandemic scenario, it was suggested the use of a larger ETT (7.0–8.0 mm for women and 8.0–9.0 mm for men), with an inflated cuff to seal the airways before ventilation, which increases the risk of injury. 31 32 33

Patients with hypoalbuminemia during hospital admission due to COVID-19 had a higher risk and positive correlation for the development of laryngotracheal injuries ( Table 1 ), which has not been found in the literature so far. Albumin provides protection against inflammatory processes and the tissue damage associated with microcirculation. 34 35 The severity of hypoalbuminemia reflects the severity of inflammatory stress in acute and chronic states, since intact innate and adaptive immune responses depend on this protein. 36 37 Its interaction with bioactive lipid mediators can contribute to the occurrence of cytokine storms. 38

Studies that evaluated the severity of infection and mortality from COVID-19 observed that patients who evolved with more severe conditions presented the following changes: increased troponin, increased arterial lactate, and changes in liver function with increased total bilirubin. 16 39 40 41 In the present study, we observed that among OIT cases in severe clinical conditions, those who presented increased troponin, total bilirubin, and arterial lactate were associated with the development of laryngotracheal injury ( Table 1 ). Therefore, we present new risk factors not described in the literature for the development of laryngotracheal injuries in patients with COVID-19 undergoing OTI.

Conclusion

We observed a higher risk for the development of laryngotracheal injury in patients who presented increased leukocyte counts with lymphopenia, increased total bilirubin, hypoalbuminemia, as well as increased arterial lactate and serum troponin at hospital admission. Patients who used higher-caliber endotracheal tubes and were submitted to pronation position, as well as those who presented higher inflammatory reactivity (increased leukocyte count) or developed coagulation disorders (increased D-dimer, PT and INR) at the time of OTI, were at higher risk for developing laryngotracheal injury.

Funding Statement

Funding The authors declare that they did not receive funding from agencies in the public, private, or non-profit sectors to conduct the present study.

Conflict of Interests The authors have no conflict of interests to declare.

Authors' Contributions

LF: study concept, data acquisition, data analysis and interpretation, writing – original draft, writing – review & editing, accountability for accuracy and integrity of the work; GSM: data acquisition, data analysis and interpretation, writing – original draft, writing – review & editing, accountability for accuracy and integrity of the work; LFB: data acquisition, data analysis and interpretation, writing – original draft, writing – review & editing, accountability for accuracy and integrity of the work; RSLT: study concept, data acquisition, data analysis and interpretation, writing – original draft, writing – review & editing, accountability for accuracy and integrity of the work; SRN: data analysis and interpretation, writing – original draft, writing – review & editing, accountability for accuracy and integrity of the work.

Data Availability Statement

Data supporting the results of this study are available upon a reasonable request from the corresponding author.

Data Availability

Data will be available upon request to the corresponding author.

Editor-in-Chief: Geraldo Pereira Jotz.

References

  • 1.Cooper J D, Grillo H C. The evolution of tracheal injury due to ventilatory assistance through cuffed tubes: a pathologic study. Ann Surg. 1969;169(03):334–348. doi: 10.1097/00000658-196903000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Stauffer J L, Olson D E, Petty T L. Complications and consequences of endotracheal intubation and tracheotomy. A prospective study of 150 critically ill adult patients. Am J Med. 1981;70(01):65–76. doi: 10.1016/0002-9343(81)90413-7. [DOI] [PubMed] [Google Scholar]
  • 3.Kastanos N, Miró R E, Perez A M, Mir A X, Agustí-Vidal A. Laryngotracheal injury due to endotracheal intubation: incidence, evolution, and predisposing factors. A prospective long-term study. Crit Care Med. 1983;11(05):362–367. doi: 10.1097/00003246-198305000-00009. [DOI] [PubMed] [Google Scholar]
  • 4.Stratakos G, Anagnostopoulos N, Alsaggaf R, Koukaki E, Bakiri K, Emmanouil P et al. COVID-19 Patients Presenting with Post-Intubation Upper Airway Complications: A Parallel Epidemic? J Clin Med. 2022;11(06):1719. doi: 10.3390/jcm11061719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Santos P M, Afrassiabi A, Weymuller E A., Jr Risk factors associated with prolonged intubation and laryngeal injury. Otolaryngol Head Neck Surg. 1994;111(04):453–459. doi: 10.1177/019459989411100411. [DOI] [PubMed] [Google Scholar]
  • 6.House J C, Noordzij J P, Murgia B, Langmore S. Laryngeal injury from prolonged intubation: a prospective analysis of contributing factors. Laryngoscope. 2011;121(03):596–600. doi: 10.1002/lary.21403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Campbell B R, Shinn J R, Kimura K S, Lowery A S, Casey J D, Ely E Q, Gelbard A. Unilateral Vocal Fold Immobility After Prolonged Endotracheal Intubation. JAMA Otolaryngol Head Neck Surg. 2020;146(02):160–167. doi: 10.1001/jamaoto.2019.3969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pasick L J, Anis M M, Rosow D E. An Updated Review of Subglottic Stenosis: Etiology, Evaluation, and Management. Curr Pulmonol Rep. 2022;11(02):29–38. doi: 10.1007/s13665-022-00286-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(05):2620–2629. doi: 10.1172/JCI137244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q et al. Intubation and ventilation amid the COVID-19 Outbreak: Wuhan's Experience. Anesthesiology. 2020;132(06):1317–1332. doi: 10.1097/ALN.0000000000003296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Poston J T, Patel B K, Davis A M. Management of Critically Ill Adults With COVID-19. JAMA. 2020;323(18):1839–1841. doi: 10.1001/jama.2020.4914. [DOI] [PubMed] [Google Scholar]
  • 12.Asik M B, Birkent H. Analysis of Age-Related Differences of Risk Factors and Comorbidities in Laryngotracheal Stenosis Patients. Indian J Otolaryngol Head Neck Surg. 2019;71 01:510–514. doi: 10.1007/s12070-018-1375-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mota L A, Cavalho GBd, Brito V A. Laryngeal complications by orotracheal intubation: Literature review. Int Arch Otorhinolaryngol. 2012;16(02):236–245. doi: 10.7162/S1809-97772012000200014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Al Saeg A A, Alnori H. Laryngeal injury and dysphonia after endotracheal intubation. J Med Life. 2021;14(03):355–360. doi: 10.25122/jml-2020-0148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Han M, Xu M, Zhang Y, Liu Z, Li S, He T et al. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity. Med Microbiol Immunol. 2020;209(06):657–668. doi: 10.1007/s00430-020-00693-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(07):934–943. doi: 10.1001/jamainternmed.2020.0994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(01):206. doi: 10.1186/s12967-020-02374-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ghosh A, Malaisrie N, Leahy K P, Singhal S, Einhorn E, Howlett P et al. Cellular adaptive inflammation mediates airway granulation in a murine model of subglottic stenosis. Otolaryngol Head Neck Surg. 2011;144(06):927–933. doi: 10.1177/0194599810397750. [DOI] [PubMed] [Google Scholar]
  • 20.Neevel A J, Smith J D, Morrison R J, Hogikyan N D, Kupfer R A, Stein A P. Postacute COVID-19 Laryngeal Injury and Dysfunction. OTO Open. 2021;5(03):2.473974E6–X211041040. doi: 10.1177/2473974X211041040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Naunheim M R, Zhou A S, Puka E, Franco Jr R A, Carroll T L, Teng S E et al. Laryngeal complications of COVID-19. Laryngoscope Investig Otolaryngol. 2020;5(06):1117–1124. doi: 10.1002/lio2.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Scholfield D W, Warner E, Ahmed J, Ghufoor K. Subglottic and tracheal stenosis associated with coronavirus disease 2019. J Laryngol Rhinol Otol. 2021;135(07):656–658. doi: 10.1017/S0022215121001134. [DOI] [PubMed] [Google Scholar]
  • 23.Crivello A, Milazzo M, La Rosa D, Fiacchini G, Danti S, Guarracino F et al. Experimental Assessment of Cuff Pressures on the Walls of a Trachea-Like Model Using Force Sensing Resistors: Insights for Patient Management in Intensive Care Unit Settings. Sensors (Basel) 2022;22(02):697. doi: 10.3390/s22020697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kim J T, Kim H J, Ahn W, Kim H S, Bahk J H, Lee S C et al. Head rotation, flexion, and extension alter endotracheal tube position in adults and children. Can J Anaesth. 2009;56(10):751–756. doi: 10.1007/s12630-009-9158-y. [DOI] [PubMed] [Google Scholar]
  • 25.Hartrey R, Kestin I G. Movement of oral and nasal tracheal tubes as a result of changes in head and neck position. Anaesthesia. 1995;50(08):682–687. doi: 10.1111/j.1365-2044.1995.tb06093.x. [DOI] [PubMed] [Google Scholar]
  • 26.Li H, Liu L, Zhang D, Xu J, Dai H, Tang Net al. SARS-CoV-2 and viral sepsis: observations and hypotheses Lancet 2020395(10235):1517–1520. 10.1016/S0140-6736(20)30920-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Zet al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020395(10229):1054–1062. 10.1016/S0140-6736(20)30566-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fiacchini G, Tricò D, Ribechini A, Forfori F, Brogi E, Lucchi M et al. Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021;147(01):70–76. doi: 10.1001/jamaoto.2020.4148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.North American Airway Collaborative (NoAAC) . Hillel A T, Karatayli-Ozgursoy S, Samad I, Best S RA, Pandian V, Giraldez L et al. Predictors of Posterior Glottic Stenosis: A Multi-Institutional Case-Control Study. Ann Otol Rhinol Laryngol. 2016;125(03):257–263. doi: 10.1177/0003489415608867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Brodsky M B, Levy M J, Jedlanek E, Pandian V, Blackford B, Price C et al. Laryngeal Injury and Upper Airway Symptoms After Oral Endotracheal Intubation With Mechanical Ventilation During Critical Care: A Systematic Review. Crit Care Med. 2018;46(12):2010–2017. doi: 10.1097/CCM.0000000000003368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cook T M, El-Boghdadly K, McGuire B, McNarry A F, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia. 2020;75(06):785–799. doi: 10.1111/anae.15054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Givi B, Schiff B A, Chinn S B, Clayburgh D, Iyer N G, Jalisi S et al. Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic. JAMA Otolaryngol Head Neck Surg. 2020;146(06):579–584. doi: 10.1001/jamaoto.2020.0780. [DOI] [PubMed] [Google Scholar]
  • 33.Brewster D J, Chrimes N, Do T B, Fraser K, Groombridge C J, Higgs A et al. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. Med J Aust. 2020;212(10):472–481. doi: 10.5694/mja2.50598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hariri G, Joffre J, Deryckere S, Bigé N, Dumas G, Baudel J L et al. Albumin infusion improves endothelial function in septic shock patients: a pilot study. Intensive Care Med. 2018;44(05):669–671. doi: 10.1007/s00134-018-5075-2. [DOI] [PubMed] [Google Scholar]
  • 35.Soeters P B, Wolfe R R, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nutr. 2019;43(02):181–193. doi: 10.1002/jpen.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gradel K O, Vinholt P J, Magnussen B, Pedersen C, Jensen T G, Kolmos H J, Lassen A T. Hypoalbuminaemia as a marker of trans-capillary leakage in community-acquired bacteraemia patients. Epidemiol Infect. 2018;146(05):648–655. doi: 10.1017/S0950268818000274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mangalmurti N, Hunter C A. Cytokine Storms: Understanding COVID-19. Immunity. 2020;53(01):19–25. doi: 10.1016/j.immuni.2020.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wiedermann C J. Hypoalbuminemia as Surrogate and Culprit of Infections. Int J Mol Sci. 2021;22(09):4496. doi: 10.3390/ijms22094496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mao R, Qiu Y, He J S, Tan J Y, Li X H, Liang J et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(07):667–678. doi: 10.1016/S2468-1253(20)30126-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wang Y, Shu H, Liu H, Li X, Zhou X, Zou X et al. The peak levels of highly sensitive troponin I predicts in-hospital mortality in COVID-19 patients with cardiac injury: a retrospective study. Eur Heart J Acute Cardiovasc Care. 2021;10(01):6–15. doi: 10.1093/ehjacc/zuaa019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Yu Y, Liu T, Shao L, Li X, He C K, Jamal M et al. Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study. Virulence. 2020;11(01):1569–1581. doi: 10.1080/21505594.2020.1840108. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data supporting the results of this study are available upon a reasonable request from the corresponding author.

Data will be available upon request to the corresponding author.


Articles from International Archives of Otorhinolaryngology are provided here courtesy of Thieme Medical Publishers

RESOURCES